Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.

Source:http://linkedlifedata.com/resource/pubmed/id/16250265

Download in:

View as

General Info

PMID
16250265